New Notices
- New Notice of Intent to Revise: Dapaglifozin Propanediol (posted 25-Apr-2025)
- New Notice of Intent to Revise: Desvenlafaxine Succinate (posted 25-Apr-2025)
- New Notice of Intent to Revise: Estradiol (posted 25-Apr-2025)
- New Notice of Intent to Revise: Isopropyl Alcohol and Azeotropic Alcohol (posted 25-Apr-2025)
- New General Announcement: Call for Data: <72> and <73> (posted 25-Apr-2025)
- FAQ: <72> and <73> (posted 25-Apr-2025)
- New General Announcement: Call for Data: <86> (posted 25-Apr-2025)
- New Notice of Intent to Revise: Choline Chloride (posted 23-Apr-2025)
- New Notice of Intent to Revise: Choline Bitartrate (posted 23-Apr-2025)
- New Notice of Intent to Revise: Metaraminol Bitartrate (posted 28-Mar-2025)
- New Notice of Intent to Revise: Somatropin and Somatropin for Injection (posted 28-Mar-2025)
- New Notice of Intent to Revise: Nefazodone (posted 28-Feb-2025)
- New Notice of Intent to Revise: Sodium Polystyrene Sulfonate Suspension (posted 28-Feb-2025)
- New Notice of Intent to Revise: Valganciclovir for Oral Solution (posted 28-Feb-2025)
- New General Announcement: Diethylene Glycol and Ethylene Glycol Testing Method for Finished Dosage Forms (posted 28-Feb-2025)
- New General Announcement: Polyethylene Glycol (posted 28-Feb-2025)
- New Notice of Intent to Revise: <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems (posted 11-Feb-2025)
- New Publication Notice: Chemical Information Updates (posted 03-Feb-2025)
- New Publication Notice: Monographs Affected by Revision to <1071> Rapid Microbiological Methods for the Detection of Contamination in Short-Life Products—A Risk-Based Approach (posted 03-Feb-2025)
- New Publication Notice: Monographs Affected by Revision to General Notices and Requirements (posted 03-Feb-2025)
- New Notice of Intent to Revise: Teriflunomide and Teriflunomide Tablets (posted 03-Feb-2025)